Compare NNOX & SMTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NNOX | SMTI |
|---|---|---|
| Founded | 2011 | 1982 |
| Country | Israel | United States |
| Employees | N/A | N/A |
| Industry | Medical Electronics | Medical/Dental Instruments |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 155.6M | 182.6M |
| IPO Year | 2019 | 2008 |
| Metric | NNOX | SMTI |
|---|---|---|
| Price | $2.21 | $16.96 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 2 |
| Target Price | $7.00 | ★ $41.00 |
| AVG Volume (30 Days) | ★ 593.1K | 70.5K |
| Earning Date | 03-31-2026 | 03-24-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $15,586,976.00 |
| Revenue This Year | $20.19 | $17.31 |
| Revenue Next Year | $137.69 | $12.48 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 32.47 |
| 52 Week Low | $2.11 | $16.05 |
| 52 Week High | $5.72 | $35.70 |
| Indicator | NNOX | SMTI |
|---|---|---|
| Relative Strength Index (RSI) | 32.56 | 36.58 |
| Support Level | $2.11 | N/A |
| Resistance Level | $2.75 | $21.14 |
| Average True Range (ATR) | 0.12 | 1.22 |
| MACD | -0.03 | -0.19 |
| Stochastic Oscillator | 6.36 | 15.32 |
Nano X Imaging Ltd is engaged in the business of manufacturing medical imaging systems. It offers a Nanox System which is a combination of hardware and software. It develops a prototype of the Nanox.ARC, a medical imaging system incorporating its novel digital X-ray source; and Nanox.CLOUD, a companion cloud-based software that will allow for the delivery of medical screening as a service. It has three business segments: Nanox.ARC division, the radiology services division and the AI solutions division. Key revenue is generated from Radiology Services.
Sanara MedTech Inc is a medical technology company focused on developing and commercializing transformative technologies to improve clinical outcomes and reduce healthcare expenditures in the chronic and surgical wound and skincare markets. Its portfolio of products and services allows it to deliver comprehensive wound and skincare solutions for patients in all care settings, including acute and post-acute. Its surgical wound care products are CellerateRX Surgical Activated Collagen. Its chronic wound care products are BIAKOS Skin and Wound Cleanser, and BIAKOS Skin and Wound Gel.